Data-Driven Regulatory Blueprint: Oncology FDA to Global Stroke Trials
A data-driven regulatory blueprint ties expedited FDA oncology routes to global stroke trial harmonization using 2024-2025 evidence. Practical checklist, audit-ready decentralized controls, and patient outcomes show how to shorten review cycles while preserving data integrity.
Robert Maxwell
Sep 12, 2025
breast cancer trials
Ischemic stroke research
Decentralized trial compliance
Cancer immunotherapy approvals